MedTrace Logo

Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury

NCT02389647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-10-29

No results posted yet for this study

Summary

The purpose of this study is to use an iatrogenic model of stroke, meaning those strokes inadvertently caused by endovascular coiling of elective aneurysms, to study the biology of stroke in humans.

Conditions

  • Cerebral Ischemia

Sponsors & Collaborators

  • Translational Genomics Research Institute

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • St. Joseph's Hospital and Medical Center, Phoenix

    lead OTHER

Principal Investigators

  • Peter Nakaji, MD · Saint Joseph's Hospital and Medical Center/Barrow Neurological Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2019-10-24
Completion
2019-10-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389647 on ClinicalTrials.gov